FIELD: pharmaceuticals.
SUBSTANCE: invention relates to the pharmaceutical industry, namely to an antiviral agent. Antiviral agent containing an aqueous solution of a water-soluble fraction of humic acids (WFHA) obtained from oxidized brown coal treated with trypsin enzyme in the ratio of WFHA and trypsin in a buffer solution with subsequent precipitation of WFHA by acidification with the content of WFHA in an aqueous solution in a concentration of from 1.5 to 150 mcg/ml, under certain conditions.
EFFECT: above described agent allows you to expand the arsenal of agents with a broad sector of antiviral action against viruses pathogenic for humans.
6 cl, 5 tbl, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| MELANINE ANTIVIRAL AGENT | 2011 |
|
RU2480227C2 |
| 2-AMINO-5,6-DIFLUOR-1-(BETA-D-RIBOFURANOSYL)-BENZIMIDAZOLE, METHOD FOR PRODUCTION AND ANTIVIRAL ACTIVITY IN TERMS OF HERPES SIMPLEX VIRUS TYPE I | 2016 |
|
RU2629670C2 |
| SARS-CoV-2 CORONAVIRUS REPLICATION INHIBITOR BASED ON HUMIC SUBSTANCES | 2020 |
|
RU2752872C1 |
| COMPOSITION SHOWING ANTI-HIV AND ANTI-HERPES ACTIVITY | 2001 |
|
RU2182828C1 |
| ANTIVIRAL AGENT BASED ON TOTAL AMOUNT OF FLAVONOIDS FROM Alchemilla vulgaris L | 2015 |
|
RU2580304C1 |
| WATER-SOLUBLE PIGMENT MELANIN FROM THE BASIDIOMYCETE INONOTUS OBLIQUUS WITH ANTIVIRAL ACTIVITY | 2022 |
|
RU2800446C1 |
| SUBTYPE A TYPE 1 IV710 HUMAN IMMUNODEFICIENCY VIRAL STRAIN RESISTANT TO ANTIRETROVIRAL PREPARATIONS FOR DIAGNOSTIC AND VACCINE PREPARATIONS | 2012 |
|
RU2513692C1 |
| N'-{N-[3-OXO-20[29]LUPEN-28-OYL]-9-AMINONONANOYL}-3-AMINO-3-PHENYLPROPIONIC ACID ELICITING IMMUNO-STIMULATING AND ANTIVIRAL ACTIVITY | 2002 |
|
RU2211843C1 |
| SUBTYPE B TYPE 1 IV735 HUMAN IMMUNODEFICIENCY VIRAL STRAIN FOR DIAGNOSTIC AND VACCINE PREPARATIONS | 2012 |
|
RU2520813C2 |
| ANTIVIRAL MEDICATION BASED ON NEMATOPHAGOUS FUNGUS Duddingtonia flagrans | 2011 |
|
RU2475531C2 |
